MedTrace Logo

Comparison of Infusion Paracetamol Protocols in PDA

NCT04469413 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 138

Last updated 2020-07-14

No results posted yet for this study

Summary

The aim of this study was to evaluate the effect of paracetamol on patent ductus arteriosus (PDA) closure and clinical outcomes in preterm infants when used as standard intermittent bolus and continuous intravenous (IV) infusion. Preterm neonates with birth weight (BW) ≤1500 g and gestational age (GA) ≤32 weeks were included in this study. During the study period, IV paracetamol therapy was given to all infants with hemodynamically significant patent ductus arteriosus (hsPDA). The patients were divided into the standard IV intermittent bolus infusion group and the continuous IV infusion group.

Conditions

  • Patent Ductus Arteriosus in Preterm Infants

Interventions

DRUG

Paracetamol Infusion

Continuous and Standard Intermittent Boluses Paracetamol Infusion

Sponsors & Collaborators

  • Ankara University

    lead OTHER

Eligibility

Max Age
1 Month
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-08-01
Completion
2020-01-06

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04469413 on ClinicalTrials.gov